Table 1 Number of non-Biobank epithelial ovarian cancer patients by source of sequencing (total before sample QC 1638; total after QC 1474).

From: Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer

Data source

Case type

Number (before/after QC)

Reference

Accession number

Exomes

UK Familial Ovarian Cancer Registry

BRCA1/2-negative with family history

53/42

Unpublished

 

Leuven

Unselected

45/44

Unpublished

 

Gilda-Radner Ovarian Cancer Registry

BRCA1/2-negative with family history

96/80

Unpublished

 

OCAC

Positive family history or <50 years of age

262/232

Unpublished

 

Mayo Clinic

Unselected

25/24

Unpublished

 

Campbell

BRCA1/2-negative high-grade serous

536/493

[40]

EGAD00001006030

Hannover

Unselected

11/7

Unpublished

 

TCGA

High grade serous

413/361

 

phs000441.v2.p6

Whole genomes

Peter MacCallum Cancer Centre

High-grade serous

93/92

[41]

EGAD00001000877

Bowtell

Long-term survivors with high-grade serous

48/46

[42]

EGAD00001009398

BRITROC

High grade serous

56/53

[43]

EGAD00001004189